Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03138889
Brief Title: A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 (Pembrolizumab) in Patients With Select Advanced or Metastatic Solid Tumors (PROPEL)

First Submitted : May 1, 2017
First Submitted that Met QC Criteria : May 1, 2017
First Posted : May 3, 2017

Last Update Submitted that Met QC Criteria : July 6, 2020
Last Update Posted : July 8, 2020 (Estimate)